Advances in Traditional Medicine

  • 제8권3호
  • /
  • Pages.207-214
  • /
  • 2008
  • /
  • 2662-4052(pISSN)
  • /
  • 2662-4060(eISSN)
경희대학교 융합한의과학연구소 (Kyung Hee Oriental Medicine Research Center)
권호 표지
DOI QR코드

DOI QR Code

Pharmacodynamic and pharmacokinetic interactions between herbs andwestern drugs

  • 발행 : 2008.09.30
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

In recent years, the combined use of Herbal medicines and Western drugs has been increasing. Though certain problems may occur when both types of medicines are taken together, they havenot been adequately analyzed. It was reported that anticoagulation was enhanced in addition tobleeding when patients took long-term warfarin therapy in combination with Salvia miltiorrhiza(danshen), and laxative herbs accelerate intestinal transit and interfere with the absorption. Herbal constituents, curcumin, ginsenosides, piperine, catechins and silymarin were found to beinhibitors of P-glycoprotein. St John's wort induces the intestinal expression of P-glycoprotein. Anthraquinone, quercetin and coumarins were found to be a potent inhibitor of P-450. Glycyrrhizin or liquorice extracts, Garlic and St John's wort are a potent inducer of CYP3A4. This review provides a critical overview of interactions between herbal medicines and other drugs. Hence, it is necessary to study the pharmacodynamic and pharmacokinetic interactions of many herbal medicines between western drugs.

키워드

참고문헌

  1. Adriane FB. (2000) Herb-drug interactions. Lancet 355, 134-138 https://doi.org/10.1016/S0140-6736(99)06457-0
  2. Almeida JC, Grimsley EW. (1996) Coma from the health food store: interaction between kava and alprazolam. Ann. Intern. Med. 125, 940-941
  3. Angelo A Izzo. (2004) Herb-drug interactions: an overview of the clinical evidence. Fundam Clin. Pharmacol. 19, 1-16
  4. Ayrton AD, Lewis DFV, Ioannides C, Walker R. (1987) Anthraflavic acid is a potent and specific inhibitor of cytochrome P-448 activity. Biochim. Biophys. Acta 916, 328-333
  5. Bailey DG, Dresser GK, Kreeft JH, Munoz C, Freeman DJ, Bend JR. (2000) Grapefruit felodipine interaction: effect of unprocessed fruit and probable active ingredients. Clin. Pharmacol. Ther. 68, 468-477 https://doi.org/10.1067/mcp.2000.110774
  6. Breinholt V, Lauridsen ST, Dragsted LO. (1999) Differential effects of dietary flavonoids on drug metabolizing and antioxidant enzymes in female rat. Xenobiotica 29, 1227-1240 https://doi.org/10.1080/004982599237903
  7. Budzinski JW, Foster BC, Vandenhoek S, Arnason JT. (2000) An in vitro evaluation of human cytochrome P450 3A4 inhibition by selected commercial herbal extracts and tinctures. Phytomedicine 7, 273-282
  8. Cai Y, Bennett D, Nair RV, Ceska O, Ashwood-Smith MJ, Diiovanni J. (1993) Inhibition and inactivation of murine hepatic ethoxy- and pentoxyresorufin O-dealkylase by naturally occurring coumarins. Chem. Res. Toxicol. 6, 872-879 https://doi.org/10.1021/tx00036a018
  9. Chan K, Cheung L. (2000) Examples of interactions between Chinese herbal medicinal products and orthodox drugs. In: Interactions between Chinese Herbal Medicinal Products and Orthodox Drugs. Harwood Academic Publishers, Amsterdam, Netherlands, 57-97
  10. Dannawi M. (2002) Possible serotonin syndrome after combination of buspirone and St John's wort. J. Psychopharmacol. 16, 401
  11. Dierks EA, Stams KR, Lim HK, Cornelius G, Zhang H, Ball SE. (2001) Amethod for the simultaneous evaluation of the activities of seven major human drug-metabolizing cytochrome P450s using an in vitro cocktail of probe substrates and fast gradient liquid chromatography tandem mass spectrometry. Drug Metab. Dispos. 29, 23-29
  12. Fumio Ikegami, Yuichi Fujii, Tetsuo Satoh. (2004) Toxicological considerations of Kampo medicines in clinical use. Toxicology 198, 221-228 https://doi.org/10.1016/j.tox.2004.01.029
  13. Gordon JB. (1998) SSRIs and St John's wort: possible toxicity? Am. Fam. Physician 57, 950
  14. Gorski JC, Huang SM, Pinto A, Hamman MA, Hilligoss JK, Zaheer NA, Desai M, Miller M, Hall SD. (2004) The effect of echinacea (Echinacea purpurea root) on cytochrome P450 activity in vivo. Clin. Pharmacol. Ther. 75, 89-100 https://doi.org/10.1016/j.clpt.2003.09.013
  15. Grant P. (2004) Warfarin and cranberry juice: an interaction. J. Heart Valve Dis. 13, 25-26
  16. Guo LQ, Taniguchi M, Chen QY, Baba K, Yamazoe Y. (2001) Inhibitory potential of herbal medicines on human cytochrome P450-mediated oxidation: properties of umbelliferous or citrus crude drugs and their relative prescriptions. Jpn. J. Pharmacol. 85, 399-408 https://doi.org/10.1254/jjp.85.399
  17. Guo LQ, Taniguchi M, Xiao YQ, Baba K, Ohta T, Yamazoe Y. (2000) Inhibitory effect of natural furanocoumarinson human microsomal cytochrome P450 3A activity. Jpn. J. Pharmacol. 82, 122-129 https://doi.org/10.1254/jjp.82.122
  18. He K, Iyer KR, Hayes RN, Sinz MW, Woolf TF, Hollenberg PF. (1998) Inactivation of cytochrome P450 3A4 by bergamottin, a component of grapefruit juice. Chem. Res. Toxicol. 11, 252-259 https://doi.org/10.1021/tx970192k
  19. Horn JR, Hansten PD. (2002) Drug interactions: answers to frequently asked questions. Pharm. Times 68, 67-78
  20. Huang SH, Duke RK, Chebib M, Sasaki K, Wada K, Johnston GA. (2004) Ginkgolides, diterpene trilactones of Ginkgo biloba, as antagonists at recombinant α1β2γ2L GABAA receptors. Eur. J. Pharmacol. 494, 131-138 https://doi.org/10.1016/j.ejphar.2004.04.051
  21. Huupponen R, Seppala P, Iisalo E. (1984) Effect of guar gum, a fibre preparation, on digoxin absorption in man. Eur. J. Clin. Pharmacol. 26, 279-281 https://doi.org/10.1007/BF00630301
  22. Ioannides C. (2002) Pharmacokinetic interactions between herbal remedies and medicinal drugs. Xenobiotica 32, 451-478 https://doi.org/10.1080/00498250210124147
  23. Ishihara K, Kushida H, Yuzurihara M, Wakui Y, Kitada M. (2000) Interaction of drugs and Chinese herbs, pharmacokinetic changes of tolbutamide and diazepam caused by extract of Angelica dahurica. J. Pharm. Pharmacol 52, 1023-1029 https://doi.org/10.1211/0022357001774750
  24. Janetzky K, Morreale AP. (1997) Probable interaction between warfarin and ginseng. Am. J. Health Syst. Pharm. 54, 692-693
  25. Jennifer A, Iqbal R. (2004) Pharmacokinetic and pharmacodynamic drug interactions with Kava (Piper methysticum Forst. f.). J. Ethnopharmacol. 93, 153-160 https://doi.org/10.1016/j.jep.2004.04.009
  26. Jiang X, Williams KM, Liauw WS, Ammit AJ, Roufogalis BD, Duke CC, Day RO, McLachlan AJ. (2004) Effect of St John's wort and ginseng on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects. Br. J. Clin. Pharmacol. 57, 592-599 https://doi.org/10.1111/j.1365-2125.2003.02051.x
  27. Johne A, Brockmoller J, Bauer S, Maurer A, Langheinrich M, Roots I. (1999) Pharmacokinetic interaction of digoxin with an herbal extract from St John's wort (Hypericum perforatum). Clin. Pharmacol. Ther. 66, 338-345 https://doi.org/10.1053/cp.1999.v66.a101944
  28. Klohs MW, Keller F, Williams RE, Toekes MI, Gronheim GE. (1959) A chemical and pharmacological investigation of Piper methysticum Forst. J. Med. Pharm. Chem. 1, 95-103 https://doi.org/10.1021/jm50002a007
  29. Kruth P, Brosi E, Fux R, Morike K, Gleiter CH. (2004) Gingerassociated overanticoagulation by phenprocoumon. Ann Pharmacother. 38, 257-260 https://doi.org/10.1345/aph.1D225
  30. Lantz MS, Buchalter E, Giambanco V. (1999) St. John's wort and antidepressant drug interactions in the elderly. J. Geriatr. Psychiatry Neurol. 12, 7-10 https://doi.org/10.1177/089198879901200103
  31. Lo ACT, Chan K, Yeung JHK, Woo KS. (1995) Danggui (Angelica sinensis) affects the pharmacodynamics but not the pharmacokinetics of warfarin in rabbits. Eur. J. Drug Metab. Pharmacokinet. 20, 55-60
  32. Markowitz JS, Donovan JL, DeVane CL, Taylor RM, Ruan Y, Wang JS, Chavin KD. (2003) Effect of St John's wort on drug metabolism by induction of cytochrome P450 3A4 enzyme. JAMA 290, 1500-1504 https://doi.org/10.1001/jama.290.11.1500
  33. Markowitz JS, Donovan JL, DeVane CL, Taylor RM, Ruan Y, Wang JS, Chavin KD. (2004) Effect of St. John's wort on drug metabolism by induction of cytochrome p450 3A4 enzyme. Obstet. Gynecol. Surv. 59, 358-359
  34. Mary LC, Melanie AJ, Pedro IC. (2006) Evidencebased drug herbal interactions. Life Sci. 78, 2146-2157 https://doi.org/10.1016/j.lfs.2005.12.009
  35. Matthews MK Jr. (1998) Association of Ginkgo biloba with intracerebral hemorrhage. Neurology 50, 1933-1934
  36. Maurer A, Johne A, Bauer S, Brockmoller J, Donath F, Roots I, Langheinrich M, Hubner WD. (1999) Interaction of St John's wort extract with phenprocoumon. Eur. J. Clin. Pharmacol. 55, A22
  37. Meenpaa J, Sigusch H, Raunio H, Syngelma T, Vuorela P, Pelkonen O. (1993) Differential inhibition of coumarin 7-hydroxylase activity in mouse and human liver microsomes. Biochem. Pharmacol. 45, 1035-1042 https://doi.org/10.1016/0006-2952(93)90247-T
  38. Meyer HJ. (1962) Pharmakologie der wirksamen prinzipien des Kawa-rhizoms (Piper methysticum Forst.). Arch Int. Pharmacodyn. Ther. 138, 505-536
  39. Mohri K, Uesawa Y. (2001) Effects of furanocoumarin derivatives in grapefruit juice on nifedipine pharmacokinetics in rats. Pharm. Res. 18, 177-182 https://doi.org/10.1023/A:1011028401189
  40. Mueller SC, Uehleke B, Woehling H, Petzsch M, Majcher-Peszynska J, Hehl EM, Sievers H, Frank B, Riethling AK, Drewelow B. (2004) Effect of St John's wort dose and preparations on the pharmacokinetics of digoxin. Clin. Pharmacol. Ther. 75, 546-557 https://doi.org/10.1016/j.clpt.2004.01.014
  41. Nordstrom M, Melander A, Robertsson E, Steen B. (1987) Influence of wheat bran and of a bulk-forming ispaghula cathartic on the bioavailability of digoxin in geriatric in-patients. Drug Nutr. Interact. 5, 67-69
  42. Ohta T, Maruyama T, Nagahashi M, Miyamoto Y, Yamazoe Y, Tsukamoto S, Paradisin C. (2002) a new CYP3A4 inhibitor from grapefruit juice. Tetrahedron 58, 6631-6635 https://doi.org/10.1016/S0040-4020(02)00739-1
  43. Page RL, Lawrence JD. (1999) Potentiation of warfarin by dong quai. Pharmacotherapy 19, 870-876 https://doi.org/10.1592/phco.19.10.870.31558
  44. Paolini M, Barillari J, Broccoli M, Pozzetti L, Perocco P, Cantelli-Forti G. (1999) Effect of liquorice and glycyrrhizin on rat liver carcinogen metabolising enzymes. Cancer Lett. 145, 35-42 https://doi.org/10.1016/S0304-3835(99)00225-6
  45. Piscitelli SC, Burstein AH, Welden N, Gallicano KD, Falloon J. (2002) The effect of garlic supplements on the pharmacokinetics of saquinavir. Clin. Infect. Dis. 34, 234-238 https://doi.org/10.1086/324351
  46. Prost N, Tichadou L, Rodor F, Nguyen N, David JM, Jean-Pastor MJ. (2000) St Johns wort-venlafaxine interaction. Presse Med. 29, 1285-1286
  47. Rosado MF. (2003) Thrombosis of a prosthetic aortic valve disclosing a hazardous interaction between warfarin and a commercial ginseng product. Cardiology 99, 111 https://doi.org/10.1159/000069720
  48. Schelosky L, Raffauf C, Jendroska K, Poewe W. (1995) Kava and dopamine antagonism. J. Neurol. Neurosurg. Psychiatr. 58, 639-640
  49. Shannon M. (1997) Drug-drug interactions and the cytochrome P450 system: an update. Pediatr. Emerg. Care 13, 350-353 https://doi.org/10.1097/00006565-199710000-00015
  50. Shannon M, Michael S. (2005) Drug-drug interactions. Pediatr. Emerg. Care 6, 93-102 https://doi.org/10.1016/j.cpem.2005.04.006
  51. Sousa RL, Marletta MA. (1985) Inhibition of cytochrome P-450 activity in rat liver microsomes by the naturally occurring flavonoid, quercetin. Arch. Biochem. Biophys. 240, 345-357 https://doi.org/10.1016/0003-9861(85)90040-2
  52. Sugimoto K, Ohmori M, Tsuruoka S, Nishiki K, Kawaguchi A, Harada K, Arakawa M, Sakamoto K, Masada M, Miyamori I, Fujimura A. (2001) Different effects of St John's wort on the pharmacokinetics of simvastatin and pravastatin. Clin. Pharmacol. Ther. 70, 518-524 https://doi.org/10.1016/S0009-9236(01)64092-X
  53. Sunter WH. (1991) Warfarin and garlic. Pharm. J. 246, 772
  54. Tannergren C, Engman H, Knutson L, Hedeland M, Bondesson U, Lennernas H. (2004) St John's wort decreases the bioavailability of R- and S-verapamil through induction of the first-pass metabolism. Clin. Pharmacol. Ther. 75, 298-309 https://doi.org/10.1016/j.clpt.2003.12.012
  55. Taylor JR, Wilt VM (1999). Probable antagonism of warfarin by green tea. Ann. Pharmacother. 33, 426-428 https://doi.org/10.1345/aph.18238
  56. Westendorf J, Keller K, Hansel R, Chandler RF. Anthranoid derivatives-general discussion. In: De Smet PAGM. Adverse effects of herbal drugs, vol 2: 105.08
  57. Yee GD, Stanley DL, Pessa L, Dalla Costa T, Beltz, SE, Ruiz J, Lowenthal DT. (1995) Effect of grapefruit juice on blood cyclosporin concentration, Lancet 345, 955-956 https://doi.org/10.1016/S0140-6736(95)90700-9
  58. Yu CM, Chan JC, Sanderson JE. (1997) Chinese herbs and warfarin potentiation by danshen. J. Intern. Med. 241, 337-339 https://doi.org/10.1046/j.1365-2796.1997.134137000.x
  59. Yue QY, Jansson K. (2001) Herbal drug and anticoagulant effect with and without warfarin: possibly related to the vitamin E component. J. Am. Geriatr. Soc. 49, 838 https://doi.org/10.1046/j.1532-5415.2001.49169.x
  60. Zhou S, Lim LY, Chowbay B. (2004) Herbal modulation of P-glycoprotein. Drug Metab. Rev. 36, 57-104 https://doi.org/10.1081/DMR-120028427
  61. Zhou S, Chan E, Pan SQ, Huang M, Lee EJ. (2004) Pharmacokinetic interactions of drugs with St John's wort. J. Psychopharmacol. 18, 262-276 https://doi.org/10.1177/0269881104042632